Treatment patterns and outcomes in patients with non‐small cell lung cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy‐induced/febrile neutropaenia: Results from the MONITOR‐GCSF study

OBJECTIVE: Real‐world evidence data on the use of granulocyte colony‐stimulating factor (G‐CSF) in patients with non‐small cell lung cancer (NSCLC) are limited. MONITOR‐GCSF is a pan‐European, multicentre, prospective, non‐interventional study designed to describe patient characteristics, treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Aapro, Matti, Krendyukov, Andriy, Höbel, Nadja, Gascon, Pere
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285596/
https://www.ncbi.nlm.nih.gov/pubmed/30968997
http://dx.doi.org/10.1111/ecc.13034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285596/
https://www.ncbi.nlm.nih.gov/pubmed/30968997
http://dx.doi.org/10.1111/ecc.13034

Ejemplares similares